![Oxidized lipid‐associated protein damage in children and adolescents with type 1 diabetes mellitus: New diagnostic/prognostic clinical markers - Kostopoulou - 2021 - Pediatric Diabetes - Wiley Online Library Oxidized lipid‐associated protein damage in children and adolescents with type 1 diabetes mellitus: New diagnostic/prognostic clinical markers - Kostopoulou - 2021 - Pediatric Diabetes - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6307fdea-1907-4477-9baa-fca7893c24e4/pedi.v22.8.cover.jpg)
Oxidized lipid‐associated protein damage in children and adolescents with type 1 diabetes mellitus: New diagnostic/prognostic clinical markers - Kostopoulou - 2021 - Pediatric Diabetes - Wiley Online Library
![Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non‐invasive or invasive)? - Avari - 2020 - Diabetic Medicine - Wiley Online Library Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non‐invasive or invasive)? - Avari - 2020 - Diabetic Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e43cf9fe-1d88-4891-af4e-c4a788786d72/dme13942-fig-0001-m.jpg)
Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non‐invasive or invasive)? - Avari - 2020 - Diabetic Medicine - Wiley Online Library
![A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes | Nutrition & Diabetes A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes | Nutrition & Diabetes](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnutd.2017.16/MediaObjects/41387_2017_Article_BFnutd201716_Fig1_HTML.jpg)
A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes | Nutrition & Diabetes
![Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d549c750-9e95-48c8-88a4-b33a3c58f07e/gr1_lrg.gif)
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology
![PDF) The Role of Natural Products on Diabetes Mellitus Treatment: A Systematic Review of Randomized Controlled Trials PDF) The Role of Natural Products on Diabetes Mellitus Treatment: A Systematic Review of Randomized Controlled Trials](https://i1.rgstatic.net/publication/357710841_The_Role_of_Natural_Products_on_Diabetes_Mellitus_Treatment_A_Systematic_Review_of_Randomized_Controlled_Trials/links/61ea96a3c5e3103375ae47dc/largepreview.png)